ORUVAIL

This brand name is authorized in Australia, Ireland, New Zealand, United Kingdom

Active ingredients

The drug ORUVAIL contains one active pharmaceutical ingredient (API):

1 Ketoprofen
UNII 90Y4QC304K - KETOPROFEN

Ketoprofen is a non-steroidal anti-inflammatory drug. It has anti-inflammatory and analgesic actions.

Read about Ketoprofen

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ORUVAIL Gel Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ORUVAIL Controlled release capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
M01AE03 Ketoprofen M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 1590Q, 5136H
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 146717, 27344, 27387, 27442, 373995
Country: IE Health Products Regulatory Authority Identifier(s): 38040
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 1804

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.